Chengwen Teng

13PUBLICATIONS
17CO-AUTHORS
Haematological tumoursOccupational epidemiologyDisease surveillanceRecordkeeping informaticsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 28, 2026
Treatment patterns and healthcare utilization for patients with relapsed or refractory (R/R) mantle cell lymphoma (MCL) in the Veterans Health Administration (MCLOVA) who were prescribed their first Bruton Tyrosine Kinase inhibitor (BTKi): A national retrospective cohort study.

|Feb 11, 2026
Age and Gender Heterogeneity in Adverse Drug Reactions Associated with Hemp Use: Evidence from the FDA Pharmacovigilance Data in the Last Two Decades.

Chengwen Teng, Jun Wu, Jing Yuan

|Oct 27, 2022
The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration's Adverse Event Reporting System (FAERS) Database.

Kalin M Clifford, Ashley R Selby, Kelly R Reveles

|Sep 23, 2022
From Start to Finish: Examining Factors Associated With Higher Likelihood of Publication Among Abstracts Presented at an International Infectious Diseases Scientific Meeting.

Asia J Johnson, Christopher M Bland, Chengwen Teng

|Jul 15, 2022
Retrospective Cohort Evaluating the Comparative Effectiveness of Ceftaroline and Daptomycin as First-Line Therapies for Inpatient Treatment of Diabetic Foot Infection in the United States Veterans Health Care System.

Alyssa C Eaves, Chengwen Teng, Kirk E Evoy

|Jul 18, 2021
Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Chengwen Teng, Christopher R Frei

Pageof 3

Frequent Collaborators

9 joint publications

Christopher Raymond Frei

3 joint publications

Zohra Nooruddin

2 joint publications

Kirk E Evoy

1 joint publications

Rachel S Britt